Resistant starch (RS) acts as insoluble fiber and by definition is resistant to enzymatic digestion in the small intestine and is non-viscous. The results of randomized controlled trials (RCTs) investigated that resistant starch(RS) supplementation on the effect of blood lipids in metabolic disorder adults have been inconsistent. The present meta-analysis aimed to quantitatively evaluate the effect of RS intervention on the concentration of blood lipids.PubMed, Cochrane, and Web of Science databases were searched up to July 2019. Mean differences were calculated on the effect of lipids by using a random-effects model. Pre-specified subgroup analyses were carried out to explore the sources of heterogeneity. Six studies (10 treatment arms) with 320 participants were identified. The result showed that RS supplementation had no significant effect on concentration of TC (-0.28 mmol/L, 95% CI: -0.68 to 0.12 mmol/L, P=0.16, I 2 =94%), TG (-0.42 mmol/L, 95% CI: -1.02 to 0.19 mmol/L, P=0.18, I 2 =99%), HDL (0.06 mmol/L, 95% CI: -0.15 to 0.27 mmol/L, P=0.57, I 2 =96%) and LDL(-0.17 mmol/L, 95% CI: -0.70 to 0.37 mmol/L, P=0.54, I 2 =94%). Subgroup analysis showed that there were decreased effect on TC concentration when RS was less than or equal to 30 g, but increased effect on TG and LDL concentration when the dose of RS was more than 30 g, and increased effect on TG in people who were overweight; no significant effect on HDL concentration no matter the dose of RS, the intervention time or the disorder status of people.